Cytochrome P450 1A2 (human) Yeast Reductase
Stability : 2 years
A cDNA was engineered to include the coding sequence for human P450 1A2 at its 5′ end (up to but not including the stop codon) fused in-frame to the coding sequence for a truncated (soluble) rat NADPH-P450 reductase at its 3′ end via an oligonucleotide sequence encoding the hydrophilic dipeptide Ser–Thr. This fusion plasmid was expressed inE. coliand the recombinant protein was purified from the detergent-solubilized membrane fraction via sequential DEAE, ADP–agarose, and hydroxylapatite chromatographies. The purified protein has the spectral characteristics of human P450 1A2 and cytochromecreduction activity comparable to rabbit NADPH-P450 reductase. The fusion protein catalyzed 7-ethoxyresorufinO-deethylation and phenacetinO-deethylation to appreciable levels in the presence of NADPH and phospholipid.
Storage : -80°C
Send inquiry online For more product information and prices
After sending the online inquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
1. Email: email@example.com（Green Stone Swiss Pharmaceutical Ingredients Manufacturer、Supplier、Exporter.）
2. Tel: +86 592 5365887
3. WhatsApp: +86 189 6515 7632
4. Send inquiry online::